MMP-9与结直肠癌侵袭转移的相关性及临床研究进展

doi:10.3760/cma.j.issn.1673-422X.2014.11.011

摘要/Abstract

摘要： 基质金属蛋白酶（MMP）-9是MMP家族相对分子质量最大的MMP，主要来源于巨噬细胞和中性粒细胞，MMP9与结直肠癌的发生及侵袭转移相关，也可以为结直肠癌的临床预防及治疗提供新的途径

Abstract: The molecular weight of matrix metalloproteinase (MMP)9 is the largest in MMP family which comes mainly from macrophage and neutrophil. MMP9 is considered to be involved in the occurrence and metastasis of colorectal cancer. It also provides a new way for colorectal cancer in clinical prevention and treatment.

Key words: Matrix metalloproteinase 9, Colorectal neoplasms, Neoplasm invasiveness, Neoplasm metastasis

胡俊杰, 许培权. MMP-9与结直肠癌侵袭转移的相关性及临床研究进展[J]. 国际肿瘤学杂志, 2014, 41(11): 833-836.

HU Jun-Jie, XU Pei-Quan. Clinical research progress between MMP-9 and the invasion and metastasis of colorectal cancer[J]. Journal of International Oncology, 2014, 41(11): 833-836.

参考文献

［1］ Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genomewide association studies［J］. Nat Rev Genet， 2009， 10（6）:353358. ［2］ Zheng X, Wang L, Zhu Y, et al. The SNP rs961253 in 20p12.3 is associated with colorectal cancer risk: a casecontrol study and a metaanalysis of the published literature［J］. PLoS One， 2012， 7:e34625. ［3］ Gezen C, Kement M, Altuntas YE, et al. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors［J］. World J Surg Oncol， 2012， 10:39. ［4］ Vandooren J, PE VDS, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase9 (MMP9): the next decade［J］. Crit Rev Biochem Mol Biol, 2013, 48(3):222272. ［5］ Groblewska M, Siewko M, Mroczko B， et al. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer［J］. Folia Histochem Cytobiol, 2012, (50):1219. ［6］ Garg P1, VijayKumar M， Wang L， et al. Matrix metalloproteinase9mediated tissue injury overrides the protective effect of matrix metalloproteinase2 during colitis［J］. Am J Physiol Gastrointest Liver Physiol, 2009, 296(2):G175184. ［7］ MotovaliBashi M, Sadeghi M, Hemmati S. Serum MMP9 level associated with initiation and progression steps of breast cancer in the Iranian population［J］. Reprod Sci, 2010, 17(6): 585589. ［8］ Lin F, Chengyao X, Qingchang L, et al. CRKL promotes lung cancer cell invasion through ERKMMP9 pathway［J］. Mol Carcinog, 2014， In press. ［9］ Wang Y, Qiu H, Hu W, et al. Overexpression of plateletderived growth factord promotes tumor growth and invasion in endometrial cancer［J］. Int J Mol Sci, 2014, 15(3):47804794. ［10］ Huang MY, Chen HC, Yang IP, et al. Tumorigenesis and tumor progression related gene expression profiles in colorectal cancer［J］. Cancer Biomark, 2013, 13(4):269279. ［11］ Dragutinovi′c VV, Radonji′c NV, Petronijevi′c ND. Matrix metalloproteinase2 (MMP2) and 9 (MMP9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.［J］. Mol Cell Biochem, 2011, 355(12):173178. ［12］ Inafuku Y, Furuhata T, Tayama M, et al. Matrix metalloproteinase2 expression in stromal tissues is a consistent prognostic factor in stage Ⅱ colon cancer［J］. Cancer Sci， 2009， 100（5）:852858. ［13］ Bendardarf R, Buhmeida A, Hilska M, et al. MMP9 (gelatinase B) expression is associated with diseasefree survival and diseasespecific survival in colorectal cancer patients［J］. Cancer Invest， 2010， 28(1):3843. ［14］田小林, 朱小宝, 郭芳, 等. 结肠直肠癌Smad4,MMP9基因表达的相关研究［J］. 癌症进展, 2010, 8(2):183188. ［15］ Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment［J］. Cell, 2010, 141(1):5267. ［16］ Roh SA, Choi EY, Cho DH, et al. Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change［J］. J Korean Med Sci, 2010, 25(3):353360. ［17］邵惠杰, 张蕾, 符仲标, 等. 结肠腺癌组织中Bmi1 和MMP9 蛋白的表达及其意义［J］. 实用医学杂志, 2011, 27(21):10065725. ［18］侯福涛, 陈子华, 钱立元. BMI1和MMP9在结肠癌细胞中的表达及意义［J］. 中国普通外科杂志, 2010, 19(10):11031106. ［19］ Lee SJ, Kim WJ, Moon SK. Role of the p38 MAPK signaling pathway in mediating interleukin28Ainduced migration of UMUC3 cells［J］. Int J Mol Med, 2012, 30（4）:945952. ［20］ Yue WY， Chen ZP． Vasculogenic mimie~potential target for tumor therapy［J］． Ai Zheng， 2006， 25(7)：914916. ［21］ WelchReardon KM, Ehsan SM, Wang K, et al .Angiogenic sprouting is regulated by endothelial cell expression of Slug (Snai2)［J］. J Cell Sci， 2014, 38(6):625633. ［22］ Li CY， Yuan P， Lin SS， et al． Matrix metalloproteinase 9 expression and prognosis in colorectal cancer ：a metaanalysis［J］． Tumour Biol， 2013， 34（2）：735741．［23］黄炳臣, 罗春英, 陆海善, 等. 大肠腺癌中HSP27和MMP9的表达及意义［J］. 右江医学, 2010, 38(4):10031383. ［24］武欣，李坤，张凡，等. 大肠癌中CCR7、Lselectin、CD44v6和MMP9表达及其与淋巴转移的关系［J］. 临床与实验病理学杂志， 2013, 29(1):3235. ［25］ RedondoMuoz J，José Terol M，GarcíaMarco JA，et al．Matrix metalloproteinase9 is upregulated by CCL2/CCR7 interaction via extracelluar signalregulated kinase1／2 signaling and is involved in CCL21driven B cell chronic lymphocytic leukemia cell invasion and migration［J］． Blood， 2008， 111(1)：383386．［26］ Li J， Sun R， Tao K， et al． The CCL21／CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase9［J］． Dig Liver Dis， 2011， 43(1)：4047. ［27］ Kim HC, Kim YS, Oh HW, et al. Collagen triple helix repeat containing 1 (CTHRC1) acts via ERKdependent induction of MMP9 to promote invasion of colorectal cancer cells.［J］. Oncotarget, 2014, 5(2):51929. ［28］ Li Y, Li Y, Liu Y, et al. PAX6, a novel target of microRNA7, promotes cellular proliferation and invasion in human colorectal cancer cells［J］. Dig Dis Sci, 2014, 59(3):598606. ［29］ Hsu TI, Lin SC, Lu PS, et al. MMP7mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy［J］. Oncogene, 2014, In press. ［30］ Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity［J］. Biochim Biophys Acta, 2010， 1803（1）:5571. ［31］ Tseng CN, Huang CF, Cho CL, et al. Brefeldin a effectively inhibits cancer stem celllike properties and MMP9 activity in human colorectal cancer Colo 205 cells［J］. Molecules, 2013, 18(9):1024210253. ［32］周太成, 杨劭宇, 罗宏图, 等. MMP9 介导结肠癌细胞sMICA蛋白脱落的研究［J］. 岭南现代临床外科, 2013, 13(4):315317.

[1]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[2]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[3]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[4]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[5]	李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵. 寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174.
[6]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹. 结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[7]	刘德宝, 孙子雯, 鲁守堂, 徐海东. ASB6在结直肠癌组织中的表达及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 470-474.
[8]	张露, 蒋华, 林州, 马辰莺, 徐晓婷, 王利利, 周菊英. 免疫检查点抑制剂治疗复发转移性宫颈癌的疗效及预后分析[J]. 国际肿瘤学杂志, 2023, 50(8): 475-483.
[9]	陈卓, 陶俊, 陈琳, 柯晶. 外周血miR-194联合粪便miR-143检测对结直肠癌临床筛查的价值[J]. 国际肿瘤学杂志, 2023, 50(5): 268-273.
[10]	杨丽蓉, 王羽丰. 预测浆液性卵巢癌术后复发远处转移风险机器学习模型的构建[J]. 国际肿瘤学杂志, 2023, 50(4): 220-226.
[11]	黄镇, 张蔡羽天, 柯少波, 石薇, 赵文思, 陈永顺. 结直肠癌患者术后预后模型的构建[J]. 国际肿瘤学杂志, 2023, 50(3): 157-163.
[12]	徐良富, 李袁飞. MSS型结直肠癌肿瘤微环境及免疫联合治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(3): 186-190.
[13]	李雄安, 颜艳艳. 丙戊酸镁用于治疗继发癫痫的晚期肺癌脑转移患者1例报道[J]. 国际肿瘤学杂志, 2023, 50(3): 191-192.
[14]	马培晗, 张灵敏, 路宁, 张明鑫. 麻醉对肝细胞癌复发转移的影响[J]. 国际肿瘤学杂志, 2023, 50(2): 117-121.
[15]	刘玉杰, 赵志强, 王子琤. 早期结直肠癌患者外周血单个核细胞中TOP2A、ERBB2的水平及其诊断价值[J]. 国际肿瘤学杂志, 2023, 50(12): 717-722.